Sinphar Pharmaceutical Co., Ltd   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Yilan Taiwan (1977)
Status: No NME R&D (1977)

Organization Overview

First Clinical Trial
2002
NCT01475578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

oxaliplatin (eloxatin) (1 trial)

Drugs in Phase 2 Trials (5)

donepezil (aricept) (1 trial)

ergoloid mesylate (1 trial)

l-epigallocatechin (1 trial)

ono-11113 (1 trial)

sta-1 (2 trials)

Drugs in Phase 1 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Angina Pectoris (Phase 2)

Angina, Stable (Phase 2)

Colorectal Neoplasms (Phase 4)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Uterine Cervical Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7